Raymond James, Third Harmonic

Raymond James Downgrades Third Harmonic Bio (THRD)
Fintel reports that on February 11, 2025, Raymond James downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from Outperform to Market Perform. Analyst Price Forecast Suggests 433.54% Upside As of January 29,
Morgan Stanley, Raymond James target new assets in 2025
The next CEO of Raymond James talks about how private equity ownership has made for some difficult marriages in wealth management, while a Morgan Stanley exec says asset outflows were unusually high last year.
Raymond James downgrades Third Harmonic Bio on uncertainty for only asset
As previously reported, Raymond James downgraded Third Harmonic Bio (THRD) to Market Perform from Outperform and removed the firm’s prior $18
Haemonetics price target lowered to $115 from $120 at Raymond James
Raymond James lowered the firm’s price target on Haemonetics (HAE) to $115 from $120 and keeps a Strong Buy rating on the shares. Shares sold
Third Harmonic stock rating cut by Raymond James
James made a notable change in their assessment of Third Harmonic (NASDAQ:HLIT) Bio (NASDAQ:THRD), downgrading the biotechnology company's stock rating from Outperform to Market Perform. According to InvestingPro data,
Third Harmonic Bio downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Third Harmonic Bio (THRD) to Market Perform from Outperform. Published first on TheFly – the ultimate source for
Raymond James Downgrades ConocoPhillips (COP)
Fintel reports that on February 10, 2025, Raymond James downgraded their outlook for ConocoPhillips (NYSE:COP) from Strong Buy to Outperform. Analyst Price Forecast Suggests 37.63% Upside As of January 28,
diginomica1h
How Raymond James uses AI-enabled observability to to gain a wealth of insight 24/7
From security to development, the wealth management firm uses the Dynatrace platform to give senior executives information on ...
Raymond James Forecasts Strong Price Appreciation for Amazon.com (NASDAQ:AMZN) Stock
Amazon.com (NASDAQ:AMZN) had its price objective boosted by equities researchers at Raymond James from $260.00 to $275.00 in ...
GovCon Wire1d
Raymond James’ Andy McEnroe on Post-Election GovTech Market
Uncover why the promises of the second Trump administration have contractors concerned about spending and acquisition funding ...
Raymond James Financial Inc. stock underperforms Monday when compared to competitors
Shares of Raymond James Financial Inc. RJF slipped 2.99% to $162.42 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to ...
Raymond James Has Negative Outlook of TSE:CF FY2025 Earnings
Stock analysts at Raymond James lowered their FY2025 EPS estimates for shares of Canaccord Genuity Group in a report issued ...
Morningstar2d
Raymond James Financial Inc RJF
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
InvestmentNews5d
LPL, Raymond James boost advisor ranks anew
LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...
Raymond James lifts USAC stock target to $30; maintains outperform
James analyst James Rollyson updated his outlook on USA Compression Partners LP (NYSE:USAC), raising the firm's price target on the stock to $30.00, up from the previous $27.00, while reiterating an ...